Design of a multi-component reaction scaffold with inhibitory activity on aspartic proteases
Markella Konstantinidou(University of California, San Francisco), Alexander Doemling, Varsha R. Jumde(University of Groningen), Muhammet Uenver(Universitätsklinikum des Saarlandes), F. Magari(Philipps University of Marburg), Anna K. H. Hirsch(University of Groningen), Fandi Sutanto(University of Groningen), G. Klebe(Lundbeck (Denmark))
Data Archiving and Networked Services (DANS)
August 25, 2019
Cited by 0
Related Papers
Covalent inhibitors: a rational approach to drug discovery
|RSC Medicinal Chemistry|2020|375
PROTACs– a game-changing technology
|Expert Opinion on Drug Discovery|2019|159
Molecular glues for protein-protein interactions: Progressing toward a new dream
|Cell chemical biology|2024|139
Immune Checkpoint PD‐1/PD‐L1: Is There Life Beyond Antibodies?
|Angewandte Chemie International Edition|2017|133
Inhibitors of programmed cell death 1 (PD-1): a patent review (2010-2015)
|Expert Opinion on Therapeutic Patents|2016|104